Active	Status	Sponsor type	Region	Phase	Filter
3 Active 3 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Chang, David W
PRIMUS006, NCT06498518: A Trial of Gemcitabine, Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreatic Cancer	Recruiting	2	50	Europe	IMM-101, Pembrolizumab, Gemcitabine	Karen Carty, NHS Greater Glasgow and Clyde, University of Glasgow	Neoplasms Pancreatic	06/27	12/27
NCT04606030: LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)	Recruiting	N/A	60	US	BioBridge® Collagen Matrix, Vascularized Lymph Node Transfer (VLNT)	Fibralign Corporation, University of Chicago	Lymphedema, Edema	12/23	02/24
NCT04161417: Precision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer	Recruiting	N/A	2500	Europe	Patients with suspected or confirmed pancreatic cancer will be be asked to provide biopsy material for molecular profiling	Judith Dixon-Hughes, Cancer Research UK, NHS Greater Glasgow and Clyde	Neoplasms Pancreatic	12/25	12/25